PLRX Q4 2022 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-1.7% YoY

Gross Profit

$912,00046.4% margin

Operating Income

-$37M-1903.3% margin

Net Income

-$35M-1784.2% margin

EPS (Diluted)

$-0.71

QoQ Revenue Growth

+32.6%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$351M

Total Liabilities

$37M

Stockholders' Equity

$313M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-1.7%
Gross Profit	$912,000	$2M	-54.4%
Operating Income	-$37M	-$25M	-52.0%
Net Income	-$35M	-$25M	-42.9%